Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Chantal Peltenburg

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scientific Reports|November 18, 2018
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapyN Chantal Peltenburg, Johannes C Schoeman, Jun Hou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral TherapyN Chantal Peltenburg, Mathie P G Leers, Jaap A Bakker, et al.
Plos One|January 13, 2018
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIVN Chantal Peltenburg, Jörgen Bierau, Jaap A Bakker, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2018
Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activityN Chantal Peltenburg, Jörgen Bierau, Jolanda A Schippers, et al.
Journal of Inherited Metabolic Disease|December 9, 2023
The management and clinical outcomes of pregnancies in women with urea cycle disorders: A review of the literature and results of an international surveyKarolina M Stepien, Janneke G Langendonk, Myriam Dao, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scientific Reports|November 18, 2018
Persistent metabolic changes in HIV-infected patients during the first year of combination antiretroviral therapyN Chantal Peltenburg, Johannes C Schoeman, Jun Hou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Inosine Triphosphate Pyrophosphohydrolase Expression: Decreased in Leukocytes of HIV-Infected Patients Using Combination Antiretroviral TherapyN Chantal Peltenburg, Mathie P G Leers, Jaap A Bakker, et al.
Plos One|January 13, 2018
Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIVN Chantal Peltenburg, Jörgen Bierau, Jaap A Bakker, et al.
The Journal of Antimicrobial Chemotherapy|October 11, 2018
Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activityN Chantal Peltenburg, Jörgen Bierau, Jolanda A Schippers, et al.
Journal of Inherited Metabolic Disease|December 9, 2023
The management and clinical outcomes of pregnancies in women with urea cycle disorders: A review of the literature and results of an international surveyKarolina M Stepien, Janneke G Langendonk, Myriam Dao, et al.
Pageof 1